Saketha Drugs And Intermediates Limited - Company Profile

It is a pharma public limited company based in Hyderabad, Telangana, India, established in 1995.

1995 Hyderabad, Telangana, India Converted to LLP

Last Updated: July 21, 2025

About Saketha Drugs And Intermediates Limited

Saketha Drugs And Intermediates Limited, a converted to llp public limited company, was established on 08 June 1995 in Hyderabad, Telangana, India. Engaging in drug formulation & development within the pharma sector, it holds CIN: U24239TG1995PLC020625. Registered under ROC Roc Hyderabad. it is unlisted. It has an authorized capital of ₹1,840.00 Cr and a paid-up capital of ₹1,828.95 Cr.

Past directors included Bandi Vamsikrishna, Chandra Sekhar Tumuluru, Parthasaradhi Reddy Bandi. Its latest AGM occurred on 26 May 2016, with the balance sheet filed on 31 March 2016. It is based at H.No.8-3-166/7/1,Third Floor, Hetero House,Erragadda, Hyderabad, Telangana, 500018.

Company Details

CIN/LLPIN
U24239TG1995PLC020625
Registration Number
020625
Incorporation Date
08 June 1995
Authorized Capital
₹1,840.00 Cr
Paid-Up Capital
₹1,828.95 Cr
ROC Code
Roc Hyderabad
Listing Status
Unlisted
Company Status
Converted to LLP

Key Metrics

Authorised Capital ₹ 1,840.00 Cr as on 21-07-2025
Paid Up Capital ₹ 1,828.95 Cr as on 21-07-2025
Company Age 30 Year, 8 Months
Last Filing with ROC 31 Mar 2016
Revenue Growth **** % (FY 2016)
Profit Growth **** 63.73% (FY 2016)
Ebitda **** 63.73% (FY 2016)
Net Worth -0.97% (FY 2016)
Total Assets **** 1.98% (FY 2016)

Comprehensive Company Insights

Explore comprehensive insights into Saketha Drugs And Intermediates Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report

Who are the key members and board of directors at Saketha Drugs And Intermediates Limited?

Past Directors

Name	Designation	Cessation	Status
Pramod Abcsdd	Director	29 Jun 2011	Past
Pramod Abcsdd	Director	19 Jan 2017	Past
Pramod Abcsdd	Director	31 Mar 2015	Past
Pramod Abcsdd	Director	29 Jun 2011	Past
Pramod Abcsdd	Director	19 Jan 2017	Past
Pramod Abcsdd	Director	19 Jan 2017	Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Saketha Drugs And Intermediates.

Saketha Drugs And Intermediates Limited, for the financial year ended 2016, experienced no change in revenue, with a 0% increase. The company also saw a substantial improvement in profitability, with a 63.73% increase in profit. The company's net worth dipped by a decrease of 0.97%.

Date	Amount	Transaction Name	Valuation	Lead Investors	Investors
Jul, 2021	Amount	Post-IPO - Grab	Valuation	investors	Emtek
Feb, 2021	Amount	Post-IPO - Grab	Valuation	investors	Signite Partners
Jan, 2021	Amount	Post-IPO - Grab	Valuation	investors	Hana Financial Group , GGV Capital
Feb, 2021	Amount	Post-IPO - Grab	Valuation	investors	Signite Partners

Upgrade Required

Full access to Financial is available only for users with an active Premium plan.

Key Matrics
Balance Sheet
Profit and Loss
Cash Flow
Ratios

Metrics

(FY 2023)

YOY Growth

(FY 2022)

(FY 2021)

(FY 2020)

(FY 2019)

Total Revenue

********

*******

Revenue from Operations

*******

Total Assets

*******

1.98%

*******

Profit or Loss

*******

63.73%

*******

Net Worth

*******

-0.97%

*******

EBITDA

*******

63.73%

*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Saketha Drugs And Intermediates?

In 2016, Saketha Drugs And Intermediates had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Shareholding Pattern (FY 2024)

Promoters: 92.83%
Public: 4.10%
Others: 3.07%

Shareholding Pattern over the Year

	FY (2024)	FY (2023)	FY (2022)	FY (2021)	FY (2020)
Promoters	92.83	94.62	94.55	94.55	94.55
Public	4.10	3.89	3.95	3.96	3.98
Others	3.07	1.49	1.50	1.49	1.47

Upgrade Required

Full access to Ownership and Shareholding Structure is available only for users with an active Premium plan.

Reveal ownership structures and financial performance - Get instant access now!

How Many Employees Work at Saketha Drugs And Intermediates?

Unlock and access historical data on people associated with Saketha Drugs And Intermediates, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Employee Date	Number of Employees
2020	78,000
2021	80,500
2022	83,200
2023	86,000
2024	89,500
2025	92,000

Upgrade Required

Full access to People is available only for users with an active Premium plan.

Deals i

Gain comprehensive insights into the Deals and Valuation data of Saketha Drugs And Intermediates, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Saketha Drugs And Intermediates's trajectory.

Rating

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Saketha Drugs And Intermediates

Recent Activity within the Organization

Annual General Meeting

Saketha Drugs And Intermediates Limited last Annual general meeting of members was held on 26 May 2016 as per latest MCA records. was recorded as a recent event.
26 May 2016
Balance Sheet

Saketha Drugs And Intermediates Limited has filed its annual Financial statements for the year ended 31 Mar 2016 with Roc Hyderabad. was recorded as a recent event.
31 Mar 2016
Company Incorporation

Progress on Saketha Drugs And Intermediates Limited was registered on 08 Jun 1995 with Roc Hyderabad & aged 30 years 8 months as per MCA records. was documented.
08 Jun 1995

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions

What is the CIN of Saketha Drugs And Intermediates Limited?

The CIN of Saketha Drugs And Intermediates Limited is U24239TG1995PLC020625.

Where is Saketha Drugs And Intermediates Limited headquartered?

Saketha Drugs And Intermediates Limited is headquartered at H.No.8-3-166/7/1,Third Floor, Hetero House,Erragadda, Hyderabad, Telangana, 500018.

When was Saketha Drugs And Intermediates Limited incorporated?

Saketha Drugs And Intermediates Limited was incorporated on 08 June 1995.

What is the primary industry of Saketha Drugs And Intermediates Limited?

The primary industry of Saketha Drugs And Intermediates Limited is Pharma.

Is Saketha Drugs And Intermediates Limited a listed company?

Saketha Drugs And Intermediates Limited is unlisted.

What is the capital structure of Saketha Drugs And Intermediates Limited?

The authorized capital of Saketha Drugs And Intermediates Limited is ₹1,840.00 Cr, and the paid-up capital is ₹1,828.95 Cr.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available